Involvement of RhoA in progression of human hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 11, 2007, Pages 1916-1920

  Wang, Desheng ^a   Dou, Kefeng ^a   Xiang, Hongjun ^a   Song, Zhenshun ^a   Zhao, Qingchuan ^a   Chen, Yong ^a   Li, Yu ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Clinicopathological correlation; Hepatocellular carcinoma; RhoA; RT PCR; Tumor progression

Indexed keywords

MESSENGER RNA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING;

EID: 34948824840     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04534.x     Document Type: Article

References (32)

1. Sonoyama T, Ochiai T, Hironaka T, Yamagishi H. Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma. Hepatogastroenterology 2003 50 : 1078 84.
2. Imamura H, Matsuyama Y, Tanaka E et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J. Hepatol. 2003 38 : 200 7.
3. Ortega S, Malumbres M, Barbacid M. Cyclin d-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta 2002 1602 : 73 87.
4. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002 420 : 629 35.
5. Aznar S, Lacal JC. Rho signals to cell growth and apoptosis. Cancer Lett. 2001 165 : 1 10.
6. Genda T, Sakamoto M, Ichida T et al. Cell motility mediated by Rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology 1999 30 : 1027 36.
7. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998 279 : 509 14.
8. Van Aelst L, D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev. 1997 11 : 2295 322.
9. Clark EA, King WG, Brugge JS et al. Integrin-mediated signals regulated by members of the rho family of GTPases. J. Cell Biol. 1998 142 : 573 86.
10. Fritz G, Just I, Kaina B. Rho GTPases are over-expressed in human tumors. Int. J. Cancer 1999 81 : 682 7.
11. Abraham MT, Kuriakose MA, Sacks PG et al. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope 2001 111 : 1285 9.
12. Moscow JA, He R, Gnarra JR et al. Examination of human tumors for rhoA mutations. Oncogene 1994 9 : 189 94.
13. Kamai T, Kawakami S, Koga F et al. RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int. 2003 91 : 234 8.
14. Yoshioka K, Matsumura F, Akedo H, Itoh K. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J. Biol. Chem. 1998 273 : 5146 54.
15. Itoh K, Yoshioka K, Akedo H et al. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat. Med. 1999 5 : 221 5.
16. Wang DS, Dou KF, Li KZ, Song ZS. Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway. World J. Gastroenterol. 2004 10 : 299 302.
17. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann. Surg. 1990 211 : 277 87.
18. Wakai T, Shirai Y, Yokoyama N et al. Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma. Eur. J. Surg. Oncol. 2003 29 : 266 71.
19. Hanazaki K, Kajikawa S, Shimozawa N et al. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology 2002 49 : 311 16.
20. Izumi R, Shimizu K, Ii T et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994 106 : 720 7.
21. Vauthey JN, Klimstra D, Franceschi D et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am. J. Surg. 1995 169 : 28 34.
22. Tada S, Iwamoto H, Nakamuta M et al. A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. J. Hepatol. 2001 34 : 529 36.
23. Murata T, Arii S, Mori A, Imamura M. Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on established liver fibrosis. J. Surg. Res. 2003 114 : 64 71.
24. Schmitz AA, Govek EE, Bottner B, Van Aelst L. Rho GTPases: signaling, migration, invasion. Exp. Cell Res. 2000 261 : 1 12.
25. Settleman J. Getting in shape with Rho. Nat. Cell Biol. 2000 2 : E7 9.
26. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995 81 : 53 62.
27. Nobes CD, Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 1999 144 : 1235 44.
28. Kamei T, Matozaki T, Sakisaka T et al. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells: regulation by Rho, Rac and Rab small G proteins. Oncogene 1999 18 : 6776 84.
29. Yoshioka K, Nakamori S, Itoh K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res. 1999 59 : 2004 10.
30. Kamai T, Yamanishi T, Shirataki H et al. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin. Cancer Res. 2004 10 : 4799 805.
31. Horiuchi A, Imai T, Wang C et al. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab. Invest. 2003 83 : 861 70.
32. Kamai T, Tsujii T, Arai K et al. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin. Cancer Res. 2003 9 : 2632 41.